Branded Generics Market Future Prospects and Forecast 2030
The report "Branded Generics Market by Disease Indication (Cardiovascular Diseases, Diabetes, Cancer, Neurological Disorders, Gastrointestinal Diseases, Dermatology Diseases, and Others), by Route of Administration (Oral, Parenteral, Topical, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Pharmacies) - Global Forecasts to 2030" The global Branded Generics Market is projected to reach USD 242.4 billion in 2023, registering at a Compound Annual Growth Rate (CAGR) of 5.9% during the forecast period 2024-2030. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=17324 Competitive Dashboard: The prominent key players operating in the global Branded Generics Market are Abbott Laboratories (U.S.) Apotex Inc. (Canada) AstraZeneca (U.K) Reddys Laboratories Ltd. (India) GlaxoSmithKline plc (U.K) Mylan N.V. (U.S.) Pfizer Inc. (U.S) Novartis AG (Switzerland) Sanofi (France) Sun Pharmace...